Recent Finacing
Recent Raise
Curemark is a drug R&D company developing CM-AT for autism and other therapies targeting neurological and dysautonomia-related conditions by addressing gastrointestinal and pancreatic secretory deficiencies and pursuing an NDA.
Focus Areas
Total Raised
Funding rounds